Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1006 AL 1020

Type I Gaucher disease with bullous pemphigoid and Parkinson disease: A case report

Le Peillet D, Prendki V, Trombert V, Laffitte E, Assal F, Reny JL, Serratrice C.

Medicine (Baltimore). 2018 Mar;97(13):e0188. doi: 10.1097/MD.0000000000010188.

Does antipsychotic drug use increase the risk of long term mortality? A systematic review and meta-analysis of observational studies

Yang C, Hao Z, Tian J, Zhang W, Li W, Zhang LL, Song F.

Oncotarget. 2018 Jan 10;9(19):15101-15110. doi: 10.18632/oncotarget.24120. eCollection 2018 Mar 13.

Alpha-synuclein is present in dental calculus but not altered in Parkinson's disease patients in comparison to controls

Schmid S, Goldberg-Bockhorn E, Schwarz S, Rotter N, Kassubek J, Del Tredici K, Pinkhardt E, Otto M, Ludolph AC, Oeckl P.

J Neurol. 2018 Jun;265(6):1334-1337. doi: 10.1007/s00415-018-8847-2. Epub 2018 Mar 29.

Supervised versus unsupervised technology-based levodopa monitoring in Parkinson's disease: an intrasubject comparison

Lopane G, Mellone S, Corzani M, Chiari L, Cortelli P, Calandra-Buonaura G, Contin M.

J Neurol. 2018 Jun;265(6):1343-1352. doi: 10.1007/s00415-018-8848-1. Epub 2018 Mar 29.

Clinical imaging in dementia with Lewy bodies

Surendranathan A, O'Brien JT.

Evid Based Ment Health. 2018 May;21(2):61-65. doi: 10.1136/eb-2017-102848. Epub 2018 Mar 29.

Disease Modification for Parkinson's Disease: Axonal Regeneration and Trophic Factors

Kordower JH, Burke RE.

Mov Disord. 2018 May;33(5):678-683. doi: 10.1002/mds.27383. Epub 2018 Mar 30.

Interventions to Prevent Falls in Community-Dwelling Older Adults: A Systematic Review for the U.S. Preventive Services Task Force

Guirguis-Blake JM, Michael YL, Perdue LA, Coppola EL, Beil TL, Thompson JH.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Apr. Report No.: 17-05232-EF-1.

Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease

Masilamoni GJ, Smith Y.

Curr Opin Pharmacol. 2018 Feb;38:72-80. doi: 10.1016/j.coph.2018.03.004. Epub 2018 Mar 30.

Paradoxical worsening of parkinsonism upon neuroleptic withdrawal: More common than we think?

Florescu A, Whitney D, Bhatti D, Bertoni JM, Torres-Russotto D.

Parkinsonism Relat Disord. 2018 Jul;52:115-116. doi: 10.1016/j.parkreldis.2018.03.018. Epub 2018 Mar 20.

Siblings with unusual presentation of early onset Parkinson's disease with dual heterozygous PARK2 and PARK 9 mutation

Chatterjee K, Choudhury S, Shubham S, Mondal B, Basu P, Kumar H.

Parkinsonism Relat Disord. 2018 Jul;52:117-118. doi: 10.1016/j.parkreldis.2018.03.017. Epub 2018 Mar 27.

Comorbid Normal Pressure Hydrocephalus with Parkinsonism: A Clinical Challenge and Call for Awareness

Cucca A, Biagioni MC, Sharma K, Golomb J, Gilbert RM, Di Rocco A, Fleisher JE.

Case Rep Neurol Med. 2018 Jan 21;2018:2513474. doi: 10.1155/2018/2513474. eCollection 2018.

Potential Use of Nanomedicine for the Anti-inflammatory Treatment of Neurodegenerative Diseases

Cayero-Otero MD, Espinosa-Oliva AM, Herrera AJ, Garcia-Dominguez I, Fernandez-Arevalo M, Martin-Banderas L, de Pablos RM.

Curr Pharm Des. 2018;24(14):1589-1616. doi: 10.2174/1381612824666180403113015.

Identifying balance impairments in people with Parkinson's disease using video and wearable sensors

Stack E, Agarwal V, King R, Burnett M, Tahavori F, Janko B, Harwin W, Ashburn A, Kunkel D.

Gait Posture. 2018 May;62:321-326. doi: 10.1016/j.gaitpost.2018.03.047. Epub 2018 Mar 28.

Nicotinic Acetylcholine Receptor Signaling: Roles in Neuroprotection

Kume T, Takada-Takatori Y.

2018 Apr 4. In: Akaike A, Shimohama S, Misu Y, editors. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias